1. Home
  2. CDTX vs MBIN Comparison

CDTX vs MBIN Comparison

Compare CDTX & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • MBIN
  • Stock Information
  • Founded
  • CDTX 2012
  • MBIN 1990
  • Country
  • CDTX United States
  • MBIN United States
  • Employees
  • CDTX N/A
  • MBIN N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MBIN Major Banks
  • Sector
  • CDTX Health Care
  • MBIN Finance
  • Exchange
  • CDTX Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • CDTX 1.4B
  • MBIN 1.4B
  • IPO Year
  • CDTX 2015
  • MBIN 2017
  • Fundamental
  • Price
  • CDTX $66.37
  • MBIN $33.29
  • Analyst Decision
  • CDTX Strong Buy
  • MBIN Buy
  • Analyst Count
  • CDTX 11
  • MBIN 3
  • Target Price
  • CDTX $57.00
  • MBIN $38.33
  • AVG Volume (30 Days)
  • CDTX 427.5K
  • MBIN 194.5K
  • Earning Date
  • CDTX 08-07-2025
  • MBIN 07-28-2025
  • Dividend Yield
  • CDTX N/A
  • MBIN 1.26%
  • EPS Growth
  • CDTX N/A
  • MBIN N/A
  • EPS
  • CDTX N/A
  • MBIN 4.55
  • Revenue
  • CDTX N/A
  • MBIN $598,079,000.00
  • Revenue This Year
  • CDTX N/A
  • MBIN $1.16
  • Revenue Next Year
  • CDTX N/A
  • MBIN $9.35
  • P/E Ratio
  • CDTX N/A
  • MBIN $6.97
  • Revenue Growth
  • CDTX N/A
  • MBIN N/A
  • 52 Week Low
  • CDTX $10.14
  • MBIN $27.25
  • 52 Week High
  • CDTX $69.36
  • MBIN $47.94
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 65.51
  • MBIN 55.07
  • Support Level
  • CDTX $59.80
  • MBIN $31.85
  • Resistance Level
  • CDTX $69.36
  • MBIN $33.40
  • Average True Range (ATR)
  • CDTX 3.83
  • MBIN 1.10
  • MACD
  • CDTX -0.38
  • MBIN 0.22
  • Stochastic Oscillator
  • CDTX 76.70
  • MBIN 91.65

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

Share on Social Networks: